Celecoxib has a better cardiorenal profile than diclofenac/ibuprofen

November 2006
Reactions Weekly;11/11/2006, Issue 1127, p1
The article discusses research being done on the cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen. It references a study by A. Whelton et al published in the October 2006 issue of "Kidney International" journal. The study found that the use of supratherapeutic doses of celecoxib appears to be associated with a reduced risk of cardiorenal adverse effects compared with therapeutic doses of ibuprofen and diclofenac in patients with rheumatoid arthritis.


Related Articles

  • Celecoxib: A Review of its Use in Osteoarthritis, Rheumatoid Arthritis and Acute Pain. Clemett, D.; Goa, K.L. // Drugs;Apr2000, Vol. 59 Issue 4, p957 

    Celecoxib is a cyclo-oxygenase (COX) inhibitor that exhibits relative in vitro and ex vivo selectivity for COX-2 over COX-1. Results of randomised double-blind multicentre studies indicate that celecoxib is superior to placebo and has similar efficacy as conventional nonsteroidal...

  • Factors associated with celecoxib, rofecoxib use in the US.  // PharmacoEconomics & Outcomes News;6/4/2005, Issue 479, p9 

    Discusses research being done on factors associated with celecoxib and rofecoxib utilization. Reference to a study by N.S. B. Rawson et al., published in the April 2005 issue of the "Annals of Pharmacotherapy"; Importance of celecoxib and rofecoxib to the treatment of rheumatoid arthritis;...

  • Etoricoxib: upper GI events less common than with diclofenac.  // Reactions Weekly;2/17/2007, Issue 1139, p4 

    The article discusses research on the association of the use of etoricoxib to treat osteoarthritis and rheumatoid arthritis with incidence of upper gastrointestinal (GI) clinical events. It references a study by L. Laine and colleagues published in the February 10, 2007 issue of "Lancet."...

  • Comparing celecoxib with traditional nonsteroidal anti-inflammatory drugs. Johnson, Melissa; Seaton, Terry // Journal of Family Practice;Feb2003, Vol. 52 Issue 2, p96 

    The article presents a study comparing the efficacy, safety and tolerability of celecoxib with other nonsteroidal anti-inflammatory drugs (NSAID) for treating osteoarthritis or rheumatoid arthritis. Celecoxib was developed to provide symptom relief without the NSAID-associated gastrointestinal...

  • COX-2 Selective Inhibitors in the Treatment of Arthritis: A Rheumatologist Perspective. Hochberg, M. C. // Current Topics in Medicinal Chemistry;Jun2005, Vol. 5 Issue 5, p443 

    COX-2 selective inhibitors were developed in order to provide similar efficacy to traditional nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) but with improved upper gastrointestinal safety. This paper presents an overview of randomized clinical trials demonstrating the efficacy of...

  • Celecoxib for Rheumatoid Arthritis. Megeff, Carla E.; Strayer, Scott M. // Journal of Family Practice;Feb2000, Vol. 49 Issue 2, p108 

    This article discusses a study on the anti-inflammatory and upper gastrointestinal effects of celecoxib on rheumatoid arthritis. The study included adult patients with a mean age of 54 years, who met the American College of Rheumatology diagnostic criteria for rheumatoid arthritis for 3 months...

  • Diclofenac + ranitidine or omeprazole beats celecoxib.  // Reactions Weekly;4/15/2006, Issue 1097/1098, p5 

    Discusses research on the cost-effectiveness of celecoxib compared with diclofenac plus either ranitidine or omeprazole on avoiding gastrointestinal events in patients with osteoarthritis. Reference to a study by S. Limwattananon et al discussed at the 2nd Asia-Pacific International Society for...

  • Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial. Neumann, V.C.; Grindulis, K.A.; Hubball, S.; McConkey, B.; Wright, V. // British Medical Journal (Clinical Research Edition);10/15/1983, Vol. 287 Issue 6399, p1099 

    Compares the efficacy of penicillamine and sulphasalazine in treating rheumatoid arthritis. Capabilities of Sulphasalazine in producing remissions; Precautions on the intake of the drugs; Concerns on the side effects of penicillamine.

  • Auranofin or D-Penicillamine in the Treatment of Rheumatoid Arthritis. Hochberg, Marc C. // Annals of Internal Medicine;Oct86, Vol. 105 Issue 4, p528 

    Presents a study which compared the effectiveness of auranofin and d-penicillamine in the treatment of rheumatoid arthritis. Patients and methods; Results; Discussion.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics